---
$id: https://graph.org.ai/products/commodity/51271907
$type: Product
source: UNSPSC
code: "51271907"
title: "Butacaine sulfate"
class: "51271900"
classTitle: "Anaesthetic aminobenzoates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butacaine sulfate

**UNSPSC Code**: 51271907
**Class**: [Anaesthetic aminobenzoates](Anaesthetic aminobenzoates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula 2C18H30N2O2.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PAU39W3CVB, chemically known as 1-propanol, 3-(dibutylamino)-, p-aminobenzoate (ester), sulfate (2:1) but generally known as butacaine sulfate, which bears US NIH Compound Identifier 120185. European Medicines Agency schedules Butacaine sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00907MIG. Most nations schedule butacaine sulfate under HS 29224995 and SITC 51465. As of Q4 2014, BUTACAINE SULFATE remains the US FDA Preferred Term for this commodity. Butacaine sulfate bears US NLM identifiers UMLS ID C0521936 and NCI Concept Code C77320. SMILES: CCCCN(CCCC)CCCOC(=O)C1=CC=C(C=C1)N.CCCCN(CCCC)CCCOC(=O)C1=CC=C(C=C1)N.OS(=O)(=O)O.

